Abstract GS02-13: Pregnancy after breast cancer in young women with germline BRCA pathogenic variants: results from an international cohort study
Matteo Lambertini(Ospedale Policlinico San Martino), Ann H. Partridge(Dana-Farber Cancer Institute), Amir Sonnenblick(Tel Aviv University), Halle C. F. Moore(Cleveland Clinic), Fedro A. Peccatori(European Institute of Oncology), Hee Jeong Kim(Ulsan College), Fabio Puglisi(University of Udine), Stephanie M. Wong(Brigham and Women's Hospital), Natalia Cichowska-Cwalińska(Gdańsk Medical University), Claudio Vernieri(Fondazione IRCCS Istituto Nazionale dei Tumori), Florian Clatot, Katarzyna Pogoda(Unknown), Luca Livraghi(Ospedale Papa Giovanni XXIII), Laura De Marchis(Policlinico Umberto I), Eva Blondeaux(Ospedale Policlinico San Martino), Kevin Punie(KU Leuven), Bela Mriňáková(Comenius University Bratislava), Carmine De Angelis(Baylor College of Medicine), Alberta Ferrari(University of Pavia), Angela Toss(University of Modena and Reggio Emilia), Hatem A. Azim(Institut Jules Bordet), Kelly‐Anne Phillips(The University of Melbourne), Alexios Matikas(Karolinska University Hospital), Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), Mahmoud Salama(National Water Research Center), Kenny A. Rodriguez‐Wallberg(Karolinska University Hospital), Martine Berlière(Cliniques Universitaires Saint-Luc), Estela Carrasco Lopez(Vall d'Hebron Hospital Universitari), Wanda Cui(The University of Melbourne), Sarah Meister(LMU Klinikum), Christine Rousset‐Jablonski(Université Claude Bernard Lyon 1), Florentine Hilbers(Breast International Group), Mariya Rozenblit(Smilow Cancer Hospital), Robert Fruscio(Azienda Ospedaliera San Gerardo), Michail Ignatiadis(Université Libre de Bruxelles), Rinat Yerushalmi(Rabin Medical Center), Ugo De Giorgi(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Lucia Del Mastro(Ospedale Policlinico San Martino), Tiphaine Renaud(Institut Bergonié), Maria Del Pilar Estevez-Diz(International Organization for Migration), Maria Vittoria Dieci(Istituto Oncologico Veneto), Elisa Agostinetto(Université Libre de Bruxelles), Cynthia Villareal Garza(Tecnológico de Monterrey), Rinat Bernstein‐Molho(Tel Aviv University), Jyoti Bajpai(Homi Bhabha National Institute), Camila Chiodi(Inserm), Icro Meattini(Azienda Ospedaliero-Universitaria Careggi), Shani Paluch–Shimon(Hebrew University of Jerusalem), Kathryn Ruddy(Mayo Clinic in Arizona), Anne‐Sophie Hamy(Université Paris Cité)
Cited by 0
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k